Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness

Metabolism: Clinical and Experimental

Volumn 61, Issue 4, 2012, Pages 482-490

  Davids, Mariska ^a   Richir, Milan C ^a   Visser, Marlieke ^a   Ellger, Björn ^b,c   Van Den Berghe, Greet ^b   Van Leeuwen, Paul A M ^a   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CONTROLLED STUDY; CRITICAL ILLNESS; ENZYME ACTIVITY; HEART; HYDROLYSIS; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

AMIDOHYDROLASES; ANIMALS; ARGININE; CRITICAL ILLNESS; KIDNEY; LIVER; MALE; MULTIVARIATE ANALYSIS; MUSCLE, SKELETAL; MYOCARDIUM; RABBITS; REGRESSION ANALYSIS;

EID: 84858451181     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.08.007     Document Type: Article

References (54)

1. S. Moncada, and E.A. Higgs The discovery of nitric oxide and its role in vascular biology Br J Pharmacol 147 2006 S193 201
2. P. Vallance, A. Leone, and A. Calver Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
3. M.P. Siroen, T. Teerlink, and R.J. Nijveldt The clinical significance of asymmetric dimethylarginine Annu Rev Nutr 26 2006 203 228
4. R.J. Nijveldt, T. Teerlink, and B. Van der Hoven Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality Clin Nutr 22 2003 23 30 (Pubitemid 36193177)
5. T. Teerlink ADMA metabolism and clearance Vasc Med 10 Suppl 1 2005 S73 S81
6. V. Achan, M. Broadhead, and M. Malaki Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase Arterioscler Thromb Vasc Biol 23 2003 1455 1459 (Pubitemid 36994536)
7. F. Palm, M.L. Onozato, and Z. Luo Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems Am J Physiol Heart Circ Physiol 293 2007 H3227 H3245
8. H. Dayoub, V. Achan, and S. Adimoolam Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis. Genetic and physiological evidence Circulation 108 2003 3042 3047 (Pubitemid 37553576)
9. K. Hasegawa, S. Wakino, and S. Tatematsu Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginine dimethylaminohydrolase 2 Circ Res 101 2007 e2 e10
10. J. Leiper, M. Nandi, and B. Torondel Disruption of methylarginine metabolism impairs vascular homeostasis Nat Med 13 2007 198 203
11. X. Hu, X. Xu, and G. Zhu Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine Circulation 120 2009 2222 2229
12. D. Wang, P.S. Gill, and T. Chabrashvili Isoform-specific regulation by NG,NG-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO Circ Res 101 2007 627 635 (Pubitemid 351325880)
13. T. Teerlink, Z. Luo, and F. Palm Cellular ADMA: regulation and action Pharmacol Res 60 2009 448 460
14. A.J. Cardounel, H. Cui, and A. Samouilov Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function J Biol Chem 282 2007 879 887 (Pubitemid 47076535)
15. G. Van den Berghe, P. Wouters, and F. Weekers Intensive insulin therapy in the critically ill patients N Engl J Med 345 2001 1359 1367
16. M.P. Siroen, P.A. Van Leeuwen, and R.J. Nijveldt Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33 2005 504 510 (Pubitemid 40365549)
17. B. Ellger, M.C. Richir, and P.A. Van Leeuwen Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity Endocrinology 149 2008 3148 3157 (Pubitemid 351724509)
18. M.P. Siroen, T. Teerlink, and A.C. Bolte No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia Gynecol Obstet Invest 62 2006 7 13 (Pubitemid 43999337)
19. T. Teerlink, P.A. Van Leeuwen, and A.P. Houdijk Plasma amino acids determined by liquid chromatography within 17 minutes Clin Chem 40 1994 245 249 (Pubitemid 24072582)
20. T. Teerlink, R.J. Nijveldt, and S. De Jong Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography Anal Biochem 303 2002 131 137 (Pubitemid 34407576)
21. S. De Jong, and T. Teerlink Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column Anal Biochem 353 2006 287 289 (Pubitemid 43775431)
22. R.J. Nijveldt, P.A. Van Leeuwen, and C. Van Guldener Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans Nephrol Dial Transplant 17 2002 1999 2002 (Pubitemid 35277101)
23. R.J. Nijveldt, T. Teerlink, and C. Van Guldener Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia Nephrol Dial Transplant 18 2003 2542 2550 (Pubitemid 37483787)
24. T. Teerlink HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids J Chromatogr B 851 2007 21 29 (Pubitemid 46720132)
25. M. Al Banchaabouchi, B. Marescau, and I. Possemiers NG,NG- dimethylarginine and NG,N'G-dimethylarginine in renal insufficiency Pflügers Arch 439 2000 524 531
26. J.R. McDermott Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit Biochem J 154 1976 179 184
27. J.T. Kielstein, R.H. Böger, and S.M. Bode-Böger Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease J Am Soc Nephrol 13 2002 170 176 (Pubitemid 34042024)
28. D. Wang, S. Strandgaard, and M.L. Borresen Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease Am J Kidney Dis 51 2008 184 191
29. M.C. Richir, R.H. Bouwman, and T. Teerlink The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function JPEN J Parenter Enteral Nutr 32 2008 613 621
30. D.E. Wilcken, A.S. Sim, and J. Wang Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolism Mol Genet Metab 91 2007 309 317 (Pubitemid 47043511)
31. M.P. Siroen, J.R. Van der Sijp, and T. Teerlink The human liver clears both asymmetric and symmetric dimethylarginine Hepatology 41 2005 559 565 (Pubitemid 40289503)
32. R.J. Nijveldt, T. Teerlink, and M.P. Siroen The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA) Clin Nutr 22 2003 17 22 (Pubitemid 36193176)
33. P. Lluch, B. Torondel, and P. Medina Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis J Hepatol 41 2004 55 59 (Pubitemid 39005153)
34. R.P. Mookerjee, M. Malaki, and N.A. Davies Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis Hepatology 45 2007 62 71 (Pubitemid 46144365)
35. R.P. Mookerjee, R.N. Dalton, and N.A. Davies Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure Liver Transpl 13 2007 400 405 (Pubitemid 46444469)
36. R.J. Nijveldt, T. Teerlink, and M.P. Siroen Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy JPEN J Parenter Enteral Nutr 28 2004 382 387 (Pubitemid 39463821)
37. M.P. Siroen, M.C. Warlé, and T. Teerlink The transplanted liver graft is capable of clearing asymmetric dimethylarginine Liver Transpl 10 2004 1524 1530 (Pubitemid 40028386)
38. T. Becker, I. Mevius, and D.K. de Vries The l-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications Nitric Oxide 20 2009 61 67
39. M.F. Lou Human muscular dystrophy: elevation of urinary dimethylarginines Science 203 1979 668 670 (Pubitemid 9149466)
40. F. Abbasi, T. Asagmi, and J.P. Cooke Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus Am J Cardiol 88 2001 1201 1203 (Pubitemid 33043860)
41. M.C. Stühlinger, F. Abbasi, and J.W. Chu Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor JAMA 287 2002 1420 1426 (Pubitemid 34250505)
42. K.Y. Lin, A. Ito, and T. Asagami Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 2002 987 992 (Pubitemid 34925335)
43. N.N. Chan, and J.C. Chan Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 45 2002 1609 1616 (Pubitemid 35478130)
44. A.D. Baron, and M.G. Clark Role of blood flow in the regulation of muscle glucose uptake Annu Rev Nutr 17 1997 487 499 (Pubitemid 27328810)
45. T. Laussmann, R.A. Janosi, and C.D. Fingas Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow FASEB J 16 2002 628 630
46. X. Chen, F. Niroomand, and Z. Liu Expression of nitric oxide related enzymes in coronary heart disease Basic Res Cardiol 101 2006 346 353 (Pubitemid 43923391)
47. Y. Chen, Y. Li, and P. Zhang Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts Am J Physiol Heart Circ Physiol 289 2005 H2212 H2219
48. H. Liu, X. Qu, and Z. Liang Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs Biochem Biophys Res Commun 377 2008 884 888
49. S. Blackwell, D.S. O'Reilly, and D. Reid Plasma dimethylarginines during the acute inflammatory response Eur J Clin Invest 41 2011 635 641
50. K.K. McDonald, S. Zharikov, and E.R. Block A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox" J Biol Chem 272 1997 31213 31216 (Pubitemid 28013248)
51. T.A. Hardy, and J.M. May Coordinate regulation of l-arginine uptake and nitric oxide synthase activity in cultured endothelial cells Free Radic Biol Med 32 2002 122 131 (Pubitemid 34127701)
52. A.J. Pope, K. Karuppiah, and P.N. Kearns Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production J Biol Chem 51 2009 35338 35347
53. L.J. Millatt, G.S. Whitley, and D. Li Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension Circulation 108 2003 1493 1498 (Pubitemid 37176457)
54. P. Bulau, D. Zakrzewicz, and K. Kitowska Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA Am J Physiol Lung Cell Mol Physiol 292 2007 L18 L24